Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 10 of 10 for “"Neglected diseases"”.
-
Essay on Incentives for Pharmaceutical Research: A Double Push -Pull Program
… understanding of the pharmaceutical market for neglected diseases and proposes a program that creates incentives and encourages research and development of new medicines for neglected diseases. The current patent system ensures that incentives are directed towards generating products that people …
-
Entrepreneurship in the public interest : varieties, effects, and the performance of entrepreneurial arrangements.
… high performance in pharmaceutical research for neglected diseases. I employ a configurational approach to analyze 195 research projects conducted in 63 public labs in Brazil, a country in which neglected diseases make up the majority of the disease burden. In the third paper I examine capability …
-
Leprosy in Brazil: How Can Brazil Meet the World Health Organization's Goal of Leprosy Control?
BACKGROUND: Leprosy causes a high social and economic cost on communities. Brazil has the second most cases of leprosy in the world. Brazil's incidence of leprosy decreased significantly with the start of multi drug therapy in 1981, but over the past ten years, the incidence has remained fairly …
-
A NEW STRATEGY FOR MOSQUITO BIOCONTROL BASED ON THE IMPROVEMENT OF BACILLUS THURINGIENSIS EFFECTIVENESS
… due to the increasing number of outbreaks of neglected diseases in these regions. Due to the lack of vaccines and prophylaxes strategies, mosquito management is a pivotal aspect to control the spread of these diseases. Beside adult stage management, larval management is also extremely …
-
Synthesis of Novel -1, 3, 5 - Triazine - Based - Anti-Tuberculosis Drugs.
… discovery. This challenge is widely visible in neglected diseases such as tuberculosis, which is an infectious disease caused by bacillus Mycobacterium tuberculosis. The urgent need in search of new biological entities to fight back TB and drug resistant TB is a drive behind this project. …
-
THE QUEST FOR ACCESS TO MEDICINES AND THE EFFECTS OF THE TRIPS AGREEMENT: AN APPRAISAL OF THE NIGERIAN SITUATION BALANCED AGAINST OTHER STATES.
… medicines for HIV/AIDS and other opportunistic diseases that are a major public health problem in Nigeria. In fulfilling the objective of this study, the thesis notes that many Nigerian laws are based on the British legal system; a historical analysis of the patent system in Britain and indeed …
-
Evaluation of Glycogen Synthase Kinase 3 as a drug target in African trypanosomes
… brucei subspecies, is one of the most neglected diseases: available treatments are old, toxic, and difficult to administer; they are not efficacious against all parasite species or disease stages and drug resistance is an increasing problem. Protein kinases are well validated drug …
-
Conceptualising the right to enjoy benefits of scientific progress and exploring its potential to enhance access to effective diagnosis and treatment of drug-resistant tuberculosis in South Africa
… is the glaring absence of scientific research in neglected diseases such as TB. This thesis sets out to elaborate the right to enjoy the benefits of scientific progress and explore its potential to increase scientific research in DR-TB and consequently enhance access to effective diagnosis and …
-
Evaluation of antihistamines for in vitro antimalarial activity against Plasmodium falciparum
… regions has amplified the world’s burden of neglected diseases. This has highlighted the need for alternate strategies for chemotherapy and chemoprophylaxis. Since malaria is prevalent primarily in third world countries, it is critical for novel therapies to be affordable. Previous research …
-
Improvement of global access to life-saving medicines. Facing the future.
This research, with the main focus on HIV/AIDS, tuberculosis and malaria, was based on data from the literature, and on questionnaire and interview surveys with the main stakeholders: authorities, drug-developers and NGOs/foundations. It revealed the following determinants, which contributed to the …